HomeTechTechnologyNvidia (NVDA) To Launch Chips For Chinese Market & Eli Lilly (LLY) Gains Weight Loss Drug Approval

Nvidia (NVDA) To Launch Chips For Chinese Market & Eli Lilly (LLY) Gains Weight Loss Drug Approval

Nvidia (NVDA) is to launch three chips for the Chinese market. NVDA stock is up 225% year-to-date. According to Reuters, NVDA’s chips for the Chinese market are expected to be announced as early as next week. These chips come after Baidu ordered chips from Huawei instead of NVDA. Kevin Green discusses this, along with how Eli Lilly (LLY) gains FDA approval for a weight loss drug, Zepbound. Zepbound helped people lose 52 pounds in 16 months in clinical trials. Tune in to find out more about the stock market today.

Trading 360

09 Nov 2023

SHARE

ON AIR
education
2:30 am
Your First Trade
replay
12:00 am
Market Overtime
REPLAY
12:30 am
Market On Close
REPLAY
education
2:00 am
Your First Trade
REPLAY
ON AIR
education
2:30 am
Your First Trade
REPLAY
3:00 am
Fast Market
REPLAY
4:00 am
Next Gen Investing
REPLAY
5:00 am
Market Overtime
REPLAY
5:30 am
The Wrap
REPLAY
7:00 am
Morning Movers
8:00 am
Opening Bell With Nicole Petallides
9:00 am
Morning Trade Live
10:00 am
Trading 360
11:00 am
Fast Market
12:00 pm
Next Gen Investing
1:00 pm
The Watch List
2:00 pm
Market On Close
3:30 pm
Market Overtime
REPLAY
4:00 pm
Fast Market
REPLAY
5:00 pm
Next Gen Investing
REPLAY
6:00 pm
The Wrap
REPLAY
education
7:30 pm
Liz Ann Live
REPLAY
8:00 pm
Market Overtime
REPLAY
8:30 pm
Market On Close
REPLAY
education
10:00 pm
Liz Ann Live
REPLAY
10:30 pm
The Wrap
REPLAY

Schwab Network's Newsletters

Daily insights for every investor